Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
This study offers valuable insights into the safety of stimulant medication use during pregnancy, highlighting the need for nuanced patient counseling and consideration of individual risks and benefits in managing ADHD symptoms.
Neurology March 12th 2024
Psychiatrist.com
The recent recall of Zenzedi 30 mg tablets due to contamination stresses the importance of meticulous medication management and awareness of the broader challenges in ADHD treatment availability and safety.
Pediatrics February 21st 2024
Psychiatry Advisor
Recent findings highlight a significant overlap between ADHD and ASD, particularly in symptomatology and diagnostic challenges. Understanding these nuances is crucial for accurate patient assessment and treatment.
Pediatrics January 23rd 2024
MDLinx
Emerging evidence suggests a nuanced relationship between diet and ADHD, highlighting the potential of micronutrients and specific dietary patterns in symptom management. Personalized nutrition strategies are gaining traction as a complement to traditional ADHD treatments.
Internal Medicine January 23rd 2024
A recent study reveals a significant association between prolonged ADHD medication use and cardiovascular risk, emphasizing the need for vigilant cardiovascular monitoring in these patients.
Cardiology January 10th 2024
The study suggests that although unlicensed doses may lead to additional symptom reduction, the gains are small and come with an increased risk of adverse events.
Psychiatry November 14th 2023